Beta Blockers and Renin–Angiotensin System Inhibitors for Preventing LV Dysfunction Due to Anthracyclines or Trastuzumab in Patients With Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer
Eur Heart J 2021 Dec 24;[EPub Ahead of Print], C Lewinter, TH Nielsen, LR Edfors, C Linde, JM Bland, M LeWinter, JGF Cleland, L Køber, F Braunschweig, A Mansson-BrobergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.